市场表现 - 道指和标普500分别上涨9点 纳斯达克上涨4点 [1] - 10年期国债收益率降至4.36% 2年期降至3.84% 30年期降至4.94% [1] 通用汽车(GM) - Q2每股收益2.53美元 超预期5.86% 营收479.8亿美元超预期1.89% [2] - 北美地区EBIT显著低于预期 股价下跌1.8% [2] 国防军工股 - 洛克希德马丁(LMT)Q2每股收益7.29美元 超预期12.33% 但营收182亿美元低于预期 股价下跌7% [3] - 诺斯罗普格鲁曼(NOC)Q2每股收益7.11美元 超预期5.96% 营收超预期2.94% 股价上涨3% [3] D.R. Horton(DHI) - Q3每股收益3.36美元 超预期15.86% 营收92.3亿美元超预期5.13% 股价上涨6% [4] - 过去一年股价累计下跌25% [4] 可口可乐(KO) - Q2每股收益0.87美元 超预期0.83美元 但营收125.4亿美元低于预期0.44% [5] - 年初至今股价累计上涨12% [5] 宣伟(SHW) - Q2每股收益3.38美元 低于预期10.11% 营收63.1亿美元超预期0.49% [6] - 股价下跌4% 年初至今转为负收益 [6] 即将公布财报公司 - 德州仪器(TXN)预计收入和利润双位数增长 [7] - Capital One(COF)预计收入和利润增长超20% [7] - Intuitive Surgical(ISRG)预计利润增长8% 收入增长16.8% [7]

市场表现 - 道指和标普500指数均上涨9点 纳斯达克指数上涨4点 [1] - 10年期国债收益率降至4.36% 2年期降至3.84% 30年期降至4.94% [1] 汽车行业 - 通用汽车(GM)Q2每股收益2.53美元超预期5.86% 营收479.8亿美元超预期1.89% [2] - 北美地区息税前利润(EBIT)低于预期 股价下跌1.8% [2] 国防工业 - 洛克希德马丁(LMT)Q2每股收益7.29美元超预期12.33% 但182亿美元营收低于预期 股价下跌7% [3] - 诺斯罗普格鲁曼(NOC)Q2每股收益7.11美元超预期5.96% 营收超预期2.94% 股价上涨3% [3] 房地产行业 - D.R. Horton(DHI)Q3每股收益3.36美元超预期15.86% 营收92.3亿美元超预期5.13% 股价上涨6% [4] - 公司股价过去一年累计下跌25% 本次上涨部分收复失地 [4] 消费品行业 - 可口可乐(KO)Q2每股收益0.87美元超预期 但125.4亿美元营收低于预期0.44% 股价小幅下跌 [5] - 公司股价年初至今仍累计上涨12% [5] - 宣伟(SHW)Q2每股收益3.38美元低于预期10.11% 营收63.1亿美元超预期0.49% 股价下跌4% [6] - 公司股价年初至今转为负收益 [6] 科技与金融行业 - 德州仪器(TXN)预计Q2利润和营收将实现两位数增长 [7] - Capital One(COF)预计利润和营收增长均超过20% [7] - Intuitive Surgical(ISRG)预计利润增长8% 营收增长16.8% [7]

GeneDx Holdings Corp. (WGS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on Jul ...

The market expects Alkermes (ALKS) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on July 29, might help the stock move higher if these key numbers are better than ex ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Penumbra (PEN) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on July 29, might help the stock move higher if these key numbers are better than expectations. On ...

UnitedHealth Group (UNH) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on July 29, might help the stock move higher if these key numbers are better than expect ...

AbCellera Biologics Inc. (ABCL) shares rallied 15% in the last trading session to close at $5.15. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 31.4% gain over the past four weeks.The sudden price rise can be attributed to growing investor optimism related to the company’s progress with its pipeline candidate, ABCL635, a first-in-class antibody that is being developed for the non-hormonal treatment of vasom ...

Steris (STE) has been on a downward spiral lately with significant selling pressure. After declining 6% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator th ...

Quest Diagnostics (DGX) Q2 2025 Earnings Call July 22, 2025 08:30 AM ET Company ParticipantsShawn Bevec - VP - IRJames Davis - Chairman, CEO, President & DirectorSam Samad - EVP & CFOKevin Caliendo - Managing DirectorElizabeth Anderson - Senior MDPatrick Donnelly - Managing DirectorNoah Kava - Equity Research AssociateConference Call ParticipantsAnn Hynes - MD & Senior Healthcare Services Equity AnalystErin Wright - AnalystMichael Cherny - Senior MD & Senior Research AnalystPito Chickering - AnalystJack Mee ...

ENGLEWOOD, Colo., July 22, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, July 31, 2025 at 4:15 PM Eastern Time to discuss its financial results for the second quarter ended June 30, 2025.  Financial results will be issued in a press release prior to the call.Zynex management will host the con ...